R. Bernabé

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Teresa Morán, Jia Wei, Manuel Cobo et al. · Annals of Oncology · 2014 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +17

PL03.12 Progression Free Survival and Overall Survival in NADIM II Study

M. Provencio, R. Serna, E. Nadal et al. · Journal of Thoracic Oncology · 2022 · 25 citations · Full text

Public Health, Biostatistics, Survival Analysis +3

A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

Enriqueta Felip, Sanjay Popat, Urania Dafni et al. · Annals of Oncology · 2025 · 22 citations · Full text

Medicine, Oncology, Pharmacology +13